Your Location:
Home >
Browse articles >
Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway
Updated:2024-12-17
Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway
- “The latest research found that Zuogui Pill can inhibit the activation of osteoclasts induced by breast cancer by activating p38 MAPK/ERK signaling pathway.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 1, Pages: 1-9(2025)
DOI: 10.13422/j.cnki.syfjx.20241822
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 6 ) Tabs( 9 )
References
Publication Info
Metrics
427
Views
371
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Anti-metastatic Effect of Zuoguiwan on Breast Cancer Cells and Its Mechanisms of Action
Traditional Chinese Medicine Regulates Related Signaling Pathways to Prevent and Control Breast Cancer and Precancerous Lesions: A Review
Exploring Mechanism of Breast Cancer Prevention by Liuwei Dihuangwan, Erzhiwan and Zuoguiwan Based on Macrophage Phagocytosis
Herbal Textual Research on Bambusae Succus in Famous Classical Formulas
Pinelliae Rhizoma and Its Prescription Compatibility for Depression Treatment: A Review
Related Author
ZOU Le-lan
LIU Hong-ning
LYU Hong
XU Huan-jun
ZHU Xiao-cui
ZHANG Zhou-miao
FU Jian-jiang
ZENG Yifei
Related Institution
Beijing Hospital of Traditional Chinese Medicine,Capital Medical University
Beijing University of Chinese Medicine
Gansu University of Chinese Medicine
Affiliated Hospital of Gansu University of Chinese Medicine
Academy of Chinese Medical Sciences, Henan University of Chinese Medicine


